AWM
UTHR icon

Activest Wealth Management’s United Therapeutics UTHR Stock Holding History

Activest Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.8K Sell
44
-7
-14% -$3.94K ﹤0.01% 410
2026
Q1 		$30.2K Sell
51
-9
-15% -$4.48K 0.01% 425
2025
Q4 		$29.2K Buy
60
+56
+1,400% +$26.1K 0.01% 419
2025
Q3 		$1.68K Hold
4
– – ﹤0.01% 803
2025
Q2 		$1.15K Buy
+4
New +$1.2K ﹤0.01% 760

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Activest Wealth Management's UTHR Position: Q2 2026 in Review

Activest Wealth Management reduced its United Therapeutics (UTHR) stake by 14% in Q2 2026, selling an estimated $3.94K and leaving 44 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #410.

Activest Wealth Management first reported a position in UTHR in Q2 2025 and has held it in 5 quarters since. The position peaked at $30.2K in Q1 2026. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Activest Wealth Management held 44 shares of United Therapeutics worth $23.8K as of Q2 2026.
  • Activest Wealth Management sold 7 United Therapeutics shares in Q2 2026, an estimated $3.94K.
  • United Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #410 holding.
  • Activest Wealth Management first reported a position in United Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Activest Wealth Management's United Therapeutics position peaked at $30.2K in Q1 2026.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.